Medical Dialogues
  • Dermatology
Login Register
This site is intended for healthcare professionals only
Login Register
  • MD Brand Connect
  • Webinars
  • Vaccine Hub
  • MDTV
    • Breaking News
    • Medical News Today
    • Health News Today
    • Latest
    • Journal Club
    • Medico Legal Update
    • Latest Webinars
    • MD Shorts
    • Health Dialogues
  • Fact Check
  • Health Dialogues
Medical Dialogues
  • Medical News & Guidelines
      • Anesthesiology
      • Cardiology and CTVS
      • Critical Care
      • Dentistry
      • Dermatology
      • Diabetes and Endocrinology
      • ENT
      • Gastroenterology
      • Medicine
      • Nephrology
      • Neurology
      • Obstretics-Gynaecology
      • Oncology
      • Ophthalmology
      • Orthopaedics
      • Pediatrics-Neonatology
      • Psychiatry
      • Pulmonology
      • Radiology
      • Surgery
      • Urology
      • Laboratory Medicine
      • Diet
      • Nursing
      • Paramedical
      • Physiotherapy
  • Health news
      • Doctor News
      • Government Policies
      • Hospital & Diagnostics
      • International Health News
      • Medical Organization News
      • Medico Legal News
      • NBE News
      • NMC News
  • Fact Check
      • Bone Health Fact Check
      • Brain Health Fact Check
      • Cancer Related Fact Check
      • Child Care Fact Check
      • Dental and oral health fact check
      • Diabetes and metabolic health fact check
      • Diet and Nutrition Fact Check
      • Eye and ENT Care Fact Check
      • Fitness fact check
      • Gut health fact check
      • Heart health fact check
      • Kidney health fact check
      • Medical education fact check
      • Men's health fact check
      • Respiratory fact check
      • Skin and hair care fact check
      • Vaccine and Immunization fact check
      • Women's health fact check
  • AYUSH
    • Ayurveda
    • Homeopathy
    • Siddha
    • Unani
    • Yoga
  • State News
      • Andaman and Nicobar Islands
      • Andhra Pradesh
      • Arunachal Pradesh
      • Assam
      • Bihar
      • Chandigarh
      • Chattisgarh
      • Dadra and Nagar Haveli
      • Daman and Diu
      • Delhi
      • Goa
      • Gujarat
      • Haryana
      • Himachal Pradesh
      • Jammu & Kashmir
      • Jharkhand
      • Karnataka
      • Kerala
      • Ladakh
      • Lakshadweep
      • Madhya Pradesh
      • Maharashtra
      • Manipur
      • Meghalaya
      • Mizoram
      • Nagaland
      • Odisha
      • Puducherry
      • Punjab
      • Rajasthan
      • Sikkim
      • Tamil Nadu
      • Telangana
      • Tripura
      • Uttar Pradesh
      • Uttrakhand
      • West Bengal
  • Medical Education
      • Ayush Education News
      • Dentistry Education News
      • Medical Admission News
      • Medical Colleges News
      • Medical Courses News
      • Medical Universities News
      • Nursing education News
      • Paramedical Education News
      • Study Abroad
  • Industry
      • Health Investment News
      • Health Startup News
      • Medical Devices News
      • Pharma News
      • Pharmacy Education News
      • Industry Perspective
  • MDTV
      • Health Dialogues MDTV
      • Health News today MDTV
      • Latest Videos MDTV
      • Latest Webinars MDTV
      • MD shorts MDTV
      • Medical News Today MDTV
      • Medico Legal Update MDTV
      • Top Videos MDTV
      • Health Perspectives MDTV
      • Journal Club MDTV
      • Medical Dialogues Show
This site is intended for healthcare professionals only
LoginRegister
Medical Dialogues
LoginRegister
  • Home
  • Medical news & Guidelines
    • Anesthesiology
    • Cardiology and CTVS
    • Critical Care
    • Dentistry
    • Dermatology
    • Diabetes and Endocrinology
    • ENT
    • Gastroenterology
    • Medicine
    • Nephrology
    • Neurology
    • Obstretics-Gynaecology
    • Oncology
    • Ophthalmology
    • Orthopaedics
    • Pediatrics-Neonatology
    • Psychiatry
    • Pulmonology
    • Radiology
    • Surgery
    • Urology
    • Laboratory Medicine
    • Diet
    • Nursing
    • Paramedical
    • Physiotherapy
  • Health news
    • Doctor News
    • Government Policies
    • Hospital & Diagnostics
    • International Health News
    • Medical Organization News
    • Medico Legal News
    • NBE News
    • NMC News
  • Fact Check
    • Bone Health Fact Check
    • Brain Health Fact Check
    • Cancer Related Fact Check
    • Child Care Fact Check
    • Dental and oral health fact check
    • Diabetes and metabolic health fact check
    • Diet and Nutrition Fact Check
    • Eye and ENT Care Fact Check
    • Fitness fact check
    • Gut health fact check
    • Heart health fact check
    • Kidney health fact check
    • Medical education fact check
    • Men's health fact check
    • Respiratory fact check
    • Skin and hair care fact check
    • Vaccine and Immunization fact check
    • Women's health fact check
  • AYUSH
    • Ayurveda
      • Ayurveda Giuidelines
      • Ayurveda News
    • Homeopathy
      • Homeopathy Guidelines
      • Homeopathy News
    • Siddha
      • Siddha Guidelines
      • Siddha News
    • Unani
      • Unani Guidelines
      • Unani News
    • Yoga
      • Yoga Guidelines
      • Yoga News
  • State News
    • Andaman and Nicobar Islands
    • Andhra Pradesh
    • Arunachal Pradesh
    • Assam
    • Bihar
    • Chandigarh
    • Chattisgarh
    • Dadra and Nagar Haveli
    • Daman and Diu
    • Delhi
    • Goa
    • Gujarat
    • Haryana
    • Himachal Pradesh
    • Jammu & Kashmir
    • Jharkhand
    • Karnataka
    • Kerala
    • Ladakh
    • Lakshadweep
    • Madhya Pradesh
    • Maharashtra
    • Manipur
    • Meghalaya
    • Mizoram
    • Nagaland
    • Odisha
    • Puducherry
    • Punjab
    • Rajasthan
    • Sikkim
    • Tamil Nadu
    • Telangana
    • Tripura
    • Uttar Pradesh
    • Uttrakhand
    • West Bengal
  • Medical Education
    • Ayush Education News
    • Dentistry Education News
    • Medical Admission News
    • Medical Colleges News
    • Medical Courses News
    • Medical Universities News
    • Nursing education News
    • Paramedical Education News
    • Study Abroad
  • Industry
    • Health Investment News
    • Health Startup News
    • Medical Devices News
    • Pharma News
      • CDSCO (Central Drugs Standard Control Organisation) News
    • Pharmacy Education News
    • Industry Perspective
  • Home
  • News
  • Industry
  • Pharma News
  • Only WHO-Compliant...

Only WHO-Compliant Formulas Can Use ORS Tag: FSSAI Cracks Down on Misleading Beverage Labels

Written By : Susmita Roy Published On 2025-10-17T21:40:53+05:30  |  Updated On 17 Oct 2025 9:40 PM IST
Only WHO-Compliant Formulas Can Use ORS Tag: FSSAI Cracks Down on Misleading Beverage Labels
  • facebook
  • twitter
  • linkedin
  • whatsapp
  • Telegram
  • Email

New Delhi: In a decision to protect consumers from misleading claims and prevent companies from marketing sugary or flavored drinks as medical rehydration solutions, the Food Safety and Standards Authority of India (FSSAI) has issued an order prohibiting the use of the term 'ORS' (Oral Rehydration Salts) on beverage labels unless the formulation strictly adheres to the World Health Organization (WHO) recommended standards.

The order marked under file number RCD-15001/6/2021-Regulatory-FSSAI—comes after an eight-year-long campaign led by pediatrician Dr Sivarajanani, who fought against the rampant misuse of the “ORS” label on commercial beverages that did not meet WHO criteria.

This directive overturns the earlier FSSAI orders issued in July 2022 and February 2024, which had placed strict labeling conditions on products using the term “ORS.” Those regulations had required manufacturers of non-WHO-compliant formulations to display a prominent front-of-pack disclaimer reading, “The product is NOT an ORS formula as recommended by WHO,” in order to safeguard consumers from misleading claims.

The FSSAI directive states,

"It is hereby clarified that, upon further review, the use of the term "ORS" in the trademarked name or in the naming of any food product otherwise-whether fruit-based, non-carbonated, or ready-to-drink beverages-even when accompanied by a prefix or suffix, constitutes a violation of the provisions of the Food Safety and Standards Act, 2006 and the regulations made thereunder."

Dr Sivarajanani’s relentless pursuit, spanning eight years of advocacy, three years of filing Public Interest Litigations (PILs), and four to five years of battling official apathy, culminated in this decisive regulatory action.

“It was a war. Eight years of battle, three years of filing PILs, and four to five years of fighting indifference. We have won—no one can use ‘ORS’ on their label unless it’s a WHO-recommended formula," the doctor expressed.

Earlier, the Medical Dialogues Team had reported that Dr Santosh previously had written to the Central Drugs Standard Control Organisation (CDSCO) and the Food Safety and Standards Authority of India (FSSAI) in this regard and already had filed a Public Interest Litigation (PIL) before the Telangana High Court.

Also Read: Promotion of Sugary Drinks? ORSL Stall at Pedicon Conference Leads to Controversy

Speaking to Medical Dialogues, Dr Sivaranjani had explained that ORSL, which is an energy drink, contains added sugar- around 10 times the recommended amount by the World Health Organization (WHO).

For years, several beverage brands had marketed flavored electrolyte drinks and fruit-based beverages as “ORS,” allegedly exploiting consumer trust in a medically recognized term. Such misbranding blurred the line between medical formulations and commercial beverages, posing public health and consumer protection risks.

According to FSSAI’s order dated October 14, 2025, no company can use “ORS” on product labels unless the formula fully matches the WHO-prescribed standard.

FSSAI’s latest order firmly restores that distinction, ensuring that only scientifically validated, WHO-aligned formulations can bear the “ORS” label. The decision aligns with FSSAI’s mandate under the Food Safety and Standards Act to prevent false, misleading, or deceptive claims in the food and beverage industry.

Following the order, FSSAI has directed all enforcement divisions and State food authorities to monitor compliance and initiate strict regulatory action against violators. Manufacturers using the “ORS” term on labels will be required to reformulate their products or remove the misleading terminology immediately.

Beverage manufacturers will be required to remove or revise any misleading ‘ORS’ labeling unless their products conform exactly to WHO-recommended ORS composition. FSSAI has instructed its enforcement divisions to monitor compliance and take strict regulatory action against violators.

Also Read: FSSAI Bans Misleading ORS Drinks That Could Aggravate Dehydration Risks

To view the official order, click the link below:

https://medicaldialogues.in/pdf_upload/ors-fssai-304978.pdf

ors label banoral rehydration saltsfood safety and standards actdr sivarajanani campaignors misuseorsl controversymisbrandingFSSAIORSORSLWHOmisleading
Susmita Roy
Susmita Roy

    Mpharm (Pharmacology)

    Susmita Roy, B pharm, M pharm Pharmacology, graduated from Gurunanak Institute of Pharmaceutical Science and Technology with a bachelor's degree in Pharmacy. She is currently working as an assistant professor at Haldia Institute of Pharmacy in West Bengal. She has been part of Medical Dialogues since March 2021.

    Show Full Article
    Next Story

    Editorial

    EASD 2025: First-Ever Guidelines Released to Address Diabetes Distress

    EASD 2025: First-Ever Guidelines Released to Address Diabetes Distress

    PRO-ACT Study Compares Topical Minoxidil 5% with PRCT vs Plain Minoxidil 5% in Androgenetic Alopecia-Combination Shows Superior Efficacy

    PRO-ACT Study Compares Topical Minoxidil 5% with PRCT vs Plain Minoxidil 5% in Androgenetic...

    DAa-ViNCI Study: Real-World Data shows Efficacy of Vildagliptin-  Dapagliflozin FDC among High-CV Risk T2D in Indian Cardiology  Settings

    DAa-ViNCI Study: Real-World Data shows Efficacy of Vildagliptin- Dapagliflozin FDC among High-CV...

    Indias Unique CV Risk Profile: How to Decode the Role of Aspirin?

    India's Unique CV Risk Profile: How to Decode the Role of Aspirin?

    Vildagliptin-Dapagliflozin FDC Effective in High CV Risk Indian T2DM Patients: Findings from Latest DAa-ViNCI Study

    Vildagliptin-Dapagliflozin FDC Effective in High CV Risk Indian T2DM Patients: Findings from Latest...

    View All

    Journal Club Today

    Menopause Timing May Influence Dementia Risk: Study Finds

    Menopause Timing May Influence Dementia Risk: Study Finds

    View All

    Health News Today

    Health Bulletin 17/October/2025

    Health Bulletin 17/October/2025

    View All
    © 2022 All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok